About
Partner at Maiwald GmbH and shareholder/managing director since 2007, Dirk Bühler advises on and manages product-related patent portfolios worldwide. He specialises in opposition, nullity and infringement proceedings and strategic IP matters in pharmaceuticals, biotechnology and personalized therapy/diagnostics, including SPC and freedom-to-operate work.
Practice areas
Intellectual PropertyPatent LitigationPharmaceuticalsBiotechnologyLife SciencesPatent Portfolio Management
Office
Expertise
PharmaceuticalsBiotechnologyPersonalized Therapy and DiagnosticsSupplementary Protection Certificates (SPC)Freedom-to-Operate (FTO) StrategiesOppositions and Nullity ProceedingsPatent Infringement and EnforcementPatent Portfolio Strategy
Education
- Doctoral degree in Biochemistry, Freie Universität Berlin (doctoral research at the Max Planck Institute for Biochemistry), 1998–2001
- Studied Biochemistry (M.Sc.), Freie Universität Berlin; University of California, Berkeley; Heidelberg University, 1992–1998
- Studied law for patent attorneys, University of Hagen, 2001–2004
Admissions
- Admitted to practice before the Unified Patent Court (UPC), 2023
- Admitted to practice as European Patent Attorney, 2004
- Admitted to practice as German Patent Attorney, 2004
Languages
GermanEnglish